Recombinant human plasma phospholipid transfer protein (pltp) to prevent bacterial growth and to treat sepsis

HIGHLIGHTS

• who: Valamp#x000E9 and rie Deckert from the INSERM LNC, UMR1231, Dijon, France University Bourgogne Franche-Comté, LNC UMR1231, Dijon, France. have published the research: Recombinant human plasma phospholipid transfer protein (PLTP) to prevent bacterial growth and to treat sepsis, in the Journal: Scientific Reports Scientific Reports of 15/02/2017
• what: This study conducted with genetically engineered mouse and rabbit models showed a dual beneficial effect of plasma PLTP in anti-microbial defenses through its ability to decrease bacterial growth and to accelerate LPS detoxification. In an attempt to satisfy the long-felt, but . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.